Skip to content
Camurus AB icon

Camurus AB

CAMX.STStocksPharmaceuticals MajorSwedenStockholm Stock ExchangeSEK

Price

SEK 737.50

Today

-0.1%

YTD

+20.2%

About

Camurus AB is a research-based pharmaceutical company focused on developing innovative, long-acting medicines to improve the lives of people with severe and chronic conditions including cancer, opioid dependence, and endocrine disease. Based in Sweden, the company operates internationally, bringing treatments to patients worldwide. Operating within the pharmaceutical and biotechnology sectors, Camurus AB specialises in developing specialty medicines based on its proprietary FluidCrystal® technology to create long-acting treatments. The aim is to develop and market innovative, differentiated medicines for significant medical needs. Monitor the CAMX.ST share price by adding it to your eToro watchlist This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.

Price chart
Closing price history for CAMX.ST (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)47.99
P/S (TTM)14.72
P/B (TTM)7.41
Market cap$32.79B
Cap tierMid-cap
Industry avg P/E-18.32

Profitability

Gross margin91.95%
EBIT margin37.27%
Net margin26.98%
ROE17.25%
ROA15.28%

Earnings & Revenue

Revenue (TTM)$2.24B
Revenue growth (1Y)+10.0%
EPS (TTM)$11.48
Free cash flow$810.62M
Total debt$110.08M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)0.79
Employees285
Next earnings11 Feb '27
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.

Camurus AB (CAMX.ST) | Dirk Kuyken